Roche Holding AG (Roche Holding AG) Total Stockholders Equity : $33,898 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Roche Holding AG Total Stockholders Equity?

Roche Holding AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $33,898 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Roche Holding AG's Book Value per Share for the quarter that ended in Dec. 2023 was $5.31. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Roche Holding AG's Debt-to-Equity for the quarter that ended in Dec. 2023 was 1.05.

Roche Holding AG Total Stockholders Equity Historical Data

The historical data trend for Roche Holding AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Total Stockholders Equity Chart

Roche Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

33,326.89

40,906.12

26,589.58

30,047.23

33,898.01

Roche Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															26,589.58	25,962.69	30,047.23	29,448.02	33,898.01

Roche Holding AG (OTCPK:RHHBY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Roche Holding AG's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(33898.011	-	0)	/	6377.94
	=	5.31

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Roche Holding AG's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5424.376	+	30169.981)	/	33898.011
	=	1.05

Roche Holding AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG (Roche Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.